Prognostic value of a left atrioventricular coupling index in pre- and post-menopausal women from the Multi-Ethnic Study of Atherosclerosis

Théo Pezel; Erin D Michos; Vinithra Varadarajan; Mahsima Shabani; Bharath Ambale Venkatesh; Dhananjay Vaidya; Yoko Kato; Henrique Doria De Vasconcellos; Susan R Heckbert; Colin O Wu; Wendy S Post; David A Bluemke; Matthew A Allison; Patrick Henry; Joao A C Lima

doi:10.3389/fcvm.2022.1066849

Prognostic value of a left atrioventricular coupling index in pre- and post-menopausal women from the Multi-Ethnic Study of Atherosclerosis

Front Cardiovasc Med. 2022 Nov 21:9:1066849. doi: 10.3389/fcvm.2022.1066849. eCollection 2022.

Authors

Théo Pezel^{1

2}, Erin D Michos¹, Vinithra Varadarajan¹, Mahsima Shabani¹, Bharath Ambale Venkatesh¹, Dhananjay Vaidya³, Yoko Kato¹, Henrique Doria De Vasconcellos¹, Susan R Heckbert⁴, Colin O Wu⁵, Wendy S Post¹, David A Bluemke⁶, Matthew A Allison⁷, Patrick Henry², Joao A C Lima¹

Affiliations

¹ Division of Cardiology, Johns Hopkins University, Baltimore, MD, United States.
² Université de Paris Cité, Service de Cardiologie, Hôpital Universitaire Lariboisière - APHP, Paris, France.
³ Department of Medicine Division of General Medicine, The Johns Hopkins University, Baltimore, MD, United States.
⁴ Department of Epidemiology, University of Washington, Seattle, WA, United States.
⁵ Division of Intramural Research, National Heart Lung and Blood Institute, Bethesda, MD, United States.
⁶ Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
⁷ Division of Preventive Medicine, Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, United States.

Abstract

Background: Sex hormones associated with both the left atrial (LA) and left ventricular (LV) structures in women, but the association of menopause status with left atrioventricular coupling is not established.

Aim: To assess the prognostic value of a left atrioventricular coupling index (LACI) in peri-menopausal women without a history of cardiovascular disease (CVD).

Materials and methods: In all women participating in MESA study with baseline cardiovascular MRI, the LACI was measured as the ratio of the LA end-diastolic volume to the LV end-diastolic volume. Cox models were used to assess the association between the LACI and the outcomes of atrial fibrillation (AF), heart failure (HF), coronary heart disease (CHD) death, and hard CVD.

Results: Among the 2,087 women participants (61 ± 10 years), 485 cardiovascular events occurred (mean follow-up: 13.2 ± 3.3 years). A higher LACI was independently associated with AF (HR 1.70; 95%CI [1.51-1.90]), HF (HR 1.62; [1.33-1.97]), CHD death (HR 1.36; [1.10-1.68]), and hard CVD (HR 1.30; [1.13-1.51], all p < 0.001). Adjusted models with the LACI showed significant improvement in model discrimination and reclassification when compared to traditional models to predict: incident AF (C-statistic: 0.82 vs. 0.79; NRI = 0.325; IDI = 0.036), HF (C-statistic: 0.84 vs. 0.81; NRI = 0.571; IDI = 0.023), CHD death (C-statistic: 0.87 vs. 0.85; NRI = 0.506; IDI = 0.012), hard CVD (C-statistic: 0.78 vs. 0.76; NRI = 0.229; IDI = 0.012). The prognostic value of the LACI had a better discrimination and reclassification than individual LA or LV parameters.

Conclusion: In a multi-ethnic population of pre- and post-menopausal women, the LACI is an independent predictor of HF, AF, CHD death, and hard CVD.

Clinical trial registration: [https://clinicaltrials.gov/], identifier [NCT00005487].

Keywords: Multi-Ethnic Study of Atherosclerosis (MESA); cardiovascular events (CVE); cardiovascular magnetic resonanace; left atrioventricular coupling; menopause; prognosis; sex hormones (SH).

Associated data

ClinicalTrials.gov/NCT00005487